Sreenath:aml: Difference between revisions
No edit summary |
No edit summary |
||
| Line 14: | Line 14: | ||
== Participants == | == Participants == | ||
'''Faculty''' | |||
Professor James 'Jake' Jacobberger (Hematology/Oncology), Director of the Cytometry Core Facility | Professor James 'Jake' Jacobberger (Hematology/Oncology), Director of the Cytometry Core Facility | ||
Sree N. Sreenath (Electrical Engineering and Computer Science) | Sree N. Sreenath (Electrical Engineering and Computer Science) | ||
'''Other''' | |||
R. Michael Sramkoski, Manager of the Cytometry Core Facility | R. Michael Sramkoski, Manager of the Cytometry Core Facility | ||
| Line 35: | Line 37: | ||
== Papers being discussed == | == Papers being discussed == | ||
All papers are available on the group's internal account. | '''All papers are available on the group's internal account.''' | ||
Disruption of Differentiation in Human Cancer: AML Shows the Way | Disruption of Differentiation in Human Cancer: AML Shows the Way | ||
Nature Reviews Cancer, 2003 | ''Nature Reviews Cancer, 2003'' | ||
Daniel Tenen | Daniel Tenen | ||
The Role of FLT3 in Hematopoietic Malignancies | The Role of FLT3 in Hematopoietic Malignancies | ||
Nature Reviews Cancer, 2003 | ''Nature Reviews Cancer, 2003'' | ||
Derek L. Stirewalt and Jerald P. Radich | Derek L. Stirewalt and Jerald P. Radich | ||
Cross-talk and decision making in MAP kinase pathways | Cross-talk and decision making in MAP kinase pathways | ||
Nature Genetics | ''Nature Genetics'' | ||
Megan N McClean, Areez Mody, James R Broach and Sharad Ramanathan | Megan N McClean, Areez Mody, James R Broach and Sharad Ramanathan | ||
Compartmental Architecture and Dynamics of Hematopoiesis | Compartmental Architecture and Dynamics of Hematopoiesis | ||
PLoS ONE, 2007 | ''PLoS ONE, 2007'' | ||
David Dingli, Arne Taulsen, Jorge M. Pacheco | David Dingli, Arne Taulsen, Jorge M. Pacheco | ||
Revision as of 12:42, 17 May 2007
CASE Complex Systems Biology Center
AML Project
Purpose
To understand the behavior of signaling mechanism in hematopoietic disorders, in particular Acute Myelogenous Leukemia (AML) using Complex Systems Biology and a data rich flow cytometry approach.
Meeting
The AML Systems Biology group meets every Friday, with alternating locations in the Wolstein conference room (WRB 3-522) and the OLIN conference room (OLIN 408). Meeting time in WRB is 9:00 to 10:00 am, while meeting time in OLIN is 9:30 to 10:30 am.
Participants
Faculty
Professor James 'Jake' Jacobberger (Hematology/Oncology), Director of the Cytometry Core Facility
Sree N. Sreenath (Electrical Engineering and Computer Science)
Other
R. Michael Sramkoski, Manager of the Cytometry Core Facility
Yehong Huong
Radina P. Soebiyanto
Michael C. Weis
Jayant Avva
Arielle Kanters
Akshai Singh
Papers being discussed
All papers are available on the group's internal account.
Disruption of Differentiation in Human Cancer: AML Shows the Way Nature Reviews Cancer, 2003 Daniel Tenen
The Role of FLT3 in Hematopoietic Malignancies Nature Reviews Cancer, 2003 Derek L. Stirewalt and Jerald P. Radich
Cross-talk and decision making in MAP kinase pathways Nature Genetics Megan N McClean, Areez Mody, James R Broach and Sharad Ramanathan
Compartmental Architecture and Dynamics of Hematopoiesis PLoS ONE, 2007 David Dingli, Arne Taulsen, Jorge M. Pacheco
